Top Clinical Trials companies in United States by Dividend Yield

This ranking features the top 530 Clinical Trials companies in United States ranked by Dividend Yield, averaging a Dividend Yield of NA, for July 08, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

…

Frequently Asked Questions

Which Clinical Trials company in United States has the highest Dividend Yield ?

The Clinical Trials company in United States with the highest Dividend Yield is Longeveron Inc. (NasdaqCM: LGVN) at 43.99%.

Which Clinical Trials company in United States has the lowest Dividend Yield ?

The Clinical Trials company in United States with the lowest Dividend Yield is Alzamend Neuro, Inc. (NasdaqCM: ALZN) at None.

What are the top 10 Clinical Trials companies in United States by Dividend Yield ?

The top 10 Clinical Trials companies in United States by Dividend Yield are Longeveron Inc., Organon & Co., Dominari Holdings Inc., Pfizer Inc., Viatris Inc., Bristol-Myers Squibb Company, BioRestorative Therapies, Inc., Fortress Biotech, Inc., Merck & Co., Inc. and AbbVie Inc..

What are the bottom 10 Clinical Trials companies in United States by Dividend Yield ?

The bottom 10 Clinical Trials companies in United States by Dividend Yield are Alzamend Neuro, Inc., Annovis Bio, Inc., Adverum Biotechnologies, Inc., Alumis Inc. Common Stock, Anebulo Pharmaceuticals, Inc., Anixa Biosciences, Inc., ABVC BioPharma, Inc., Actuate Therapeutics Inc, Aldeyra Therapeutics, Inc. and Applied DNA Sciences, Inc..